Metoprolol Carinopharm

Metoprolol Tartrate, the active ingredient in Metoprolol Carinopharm, is a beta blocker presented as an injectable solution for intravenous use. It treats hypertension, angina pectoris, acute myocardial infarction and cardiac arrhythmias in adult patients, helping to lower heart rate and myocardial oxygen demand.\n\nGNH India supplies Metoprolol Carinopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Carinopharm, a selective β1‑adrenergic blocker, is used in cardiovascular conditions where reduction of heart rate and myocardial oxygen demand is desired.\n\nHypertension: lowers blood pressure by decreasing cardiac output.\nAngina pectoris: reduces frequency of chest‑pain episodes by lowering myocardial oxygen consumption.\nAcute myocardial infarction: improves survival by limiting cardiac workload and arrhythmias.\nCardiac arrhythmias: controls ventricular rate in atrial fibrillation and other supraventricular tachyarrhythmias.

Common Side Effects:\n- Fatigue or weakness\n- Dizziness or light‑headedness\n- Bradycardia (slow heart rate)\n- Cold extremities\n- Headache\n- Gastrointestinal upset (nausea, abdominal discomfort)\n\nSerious or Rare Side Effects:\n- Severe bradycardia or heart block\n- Marked hypotension\n- Acute heart failure exacerbation\n- Bronchospasm, especially in patients with asthma or COPD\n- Allergic reactions including rash, angioedema or anaphylaxis\n- Cardiogenic shock in high‑risk patients

Metoprolol Carinopharm should be used with careful clinical monitoring in patients with existing cardiac conduction disorders.\n\nCardiovascular monitoring: observe heart rate and blood pressure during initiation and dose adjustments.\nRenal or hepatic impairment: consider dose reduction and monitor drug levels.\nAbrupt discontinuation: taper gradually to avoid rebound hypertension or tachycardia.\nRespiratory caution: use with caution in patients with asthma or chronic obstructive pulmonary disease.\nDiabetes management: monitor blood glucose as β‑blockade may mask hypoglycaemic symptoms.\nStore at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Metoprolol Carinopharm may interact with several cardiovascular agents.\n\nMajor Interactions (Avoid):\n- Co‑administration with verapamil or diltiazem can cause profound bradycardia and AV‑block.\n- Concurrent use of other β‑blockers may lead to excessive β‑blockade.\n- Combination with clonidine may precipitate severe rebound hypertension on abrupt withdrawal.\n\nModerate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs may enhance hypotensive effects.\n- Diuretics can increase the risk of orthostatic hypotension.\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs) may reduce antihypertensive efficacy.